Convatec Group Plc (Convatec) AGM trading update for the four months ended 30 April 2023.
Convatec Group Plc, a global medical products and technologies company, published an AGM trading update for the four months ended 30 April 2023. Organic revenue increased by 3.1%, while reported revenue decreased by 1.7% after the exit of hospital care activities and related industrial sales in 2022.
The company raised its 2023 organic revenue growth guidance to between 5.0% and 6.5% and expects its constant currency operating profit margin to reach at least 19.7%. The update also covers strategic progress, including an anti-infective technology acquisition, plant network optimization, and new product innovation.
Organic revenue increased by 3.1% on an organic basis for the four months ended 30 April 2023.
Convatec now expects organic revenue growth for 2023 to be between 5.0% and 6.5%.
The company expects to increase its operating profit margin on a constant currency basis to at least 19.7%.